These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39324549)

  • 1. FcRn-enhancing mutations lead to increased and prolonged levels of the HIV CCR5-blocking monoclonal antibody leronlimab in the fetuses and newborns of pregnant rhesus macaques.
    Zikos J; Webb GM; Wu HL; Reed JS; Watanabe J; Usachenko JL; Shaqra AM; Schiffer CA; Van Rompay KKA; Sacha JB; Magnani DM
    MAbs; 2024; 16(1):2406788. PubMed ID: 39324549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the Role of a Second Fc-Binding Receptor in Placental IgG Transfer in Nonhuman Primates.
    Rosenberg YJ; Ordonez T; Khanwalkar US; Barnette P; Pandey S; Backes IM; Otero CE; Goldberg BS; Crowley AR; Leib DA; Shapiro MB; Jiang X; Urban LA; Lees J; Hessell AJ; Permar S; Haigwood NL; Ackerman ME
    mBio; 2023 Apr; 14(2):e0034123. PubMed ID: 36946726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR5 Receptor Occupancy Analysis Reveals Increased Peripheral Blood CCR5+CD4+ T Cells Following Treatment With the Anti-CCR5 Antibody Leronlimab.
    Chang XL; Wu HL; Webb GM; Tiwary M; Hughes C; Reed JS; Hwang J; Waytashek C; Boyle C; Pessoa C; Sylwester AW; Morrow D; Belica K; Fischer M; Kelly S; Pourhassan N; Bochart RM; Smedley J; Recknor CP; Hansen SG; Sacha JB
    Front Immunol; 2021; 12():794638. PubMed ID: 34868084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcRn, but not FcγRs, drives maternal-fetal transplacental transport of human IgG antibodies.
    Borghi S; Bournazos S; Thulin NK; Li C; Gajewski A; Sherwood RW; Zhang S; Harris E; Jagannathan P; Wang LX; Ravetch JV; Wang TT
    Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12943-12951. PubMed ID: 32461366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.
    Ko SY; Pegu A; Rudicell RS; Yang ZY; Joyce MG; Chen X; Wang K; Bao S; Kraemer TD; Rath T; Zeng M; Schmidt SD; Todd JP; Penzak SR; Saunders KO; Nason MC; Haase AT; Rao SS; Blumberg RS; Mascola JR; Nabel GJ
    Nature; 2014 Oct; 514(7524):642-5. PubMed ID: 25119033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between an IgG3 polymorphism in the binding domain for FcRn, transplacental transfer of malaria-specific IgG3, and protection against Plasmodium falciparum malaria during infancy: A birth cohort study in Benin.
    Dechavanne C; Dechavanne S; Sadissou I; Lokossou AG; Alvarado F; Dambrun M; Moutairou K; Courtin D; Nuel G; Garcia A; Migot-Nabias F; King CL
    PLoS Med; 2017 Oct; 14(10):e1002403. PubMed ID: 28991911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternofetal transplacental transport of recombinant IgG antibodies lacking effector functions.
    Mathiesen L; Nielsen LK; Andersen JT; Grevys A; Sandlie I; Michaelsen TE; Hedegaard M; Knudsen LE; Dziegiel MH
    Blood; 2013 Aug; 122(7):1174-81. PubMed ID: 23843496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of novel Fc-engineered monoclonal and multispecific antibodies in cynomolgus monkeys and humanized FcRn transgenic mouse models.
    Valente D; Mauriac C; Schmidt T; Focken I; Beninga J; Mackness B; Qiu H; Vicat P; Kandira A; Radošević K; Rao S; Darbyshire J; Kabiri M
    MAbs; 2020; 12(1):1829337. PubMed ID: 33079615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are endosomal trafficking parameters better targets for improving mAb pharmacokinetics than FcRn binding affinity?
    Gurbaxani B; Dostalek M; Gardner I
    Mol Immunol; 2013 Dec; 56(4):660-74. PubMed ID: 23917469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy.
    Chen P; Li C; Lang S; Zhu G; Reheman A; Spring CM; Freedman J; Ni H
    Blood; 2010 Nov; 116(18):3660-8. PubMed ID: 20647570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human and simian immunodeficiency virus replication with the CCR5-specific antibody Leronlimab in two species.
    Chang XL; Reed JS; Webb GM; Wu HL; Le J; Bateman KB; Greene JM; Pessoa C; Waytashek C; Weber WC; Hwang J; Fischer M; Moats C; Shiel O; Bochart RM; Crank H; Siess D; Giobbi T; Torgerson J; Agnor R; Gao L; Dhody K; Lalezari JP; Bandar IS; Carnate AM; Pang AS; Corley MJ; Kelly S; Pourhassan N; Smedley J; Bimber BN; Hansen SG; Ndhlovu LC; Sacha JB
    PLoS Pathog; 2022 Mar; 18(3):e1010396. PubMed ID: 35358290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics.
    Piche-Nicholas NM; Avery LB; King AC; Kavosi M; Wang M; O'Hara DM; Tchistiakova L; Katragadda M
    MAbs; 2018 Jan; 10(1):81-94. PubMed ID: 28991504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
    Coutinho E; Jacobson L; Shock A; Smith B; Vernon A; Vincent A
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34045306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody.
    Monnet C; Jorieux S; Souyris N; Zaki O; Jacquet A; Fournier N; Crozet F; de Romeuf C; Bouayadi K; Urbain R; Behrens CK; Mondon P; Fontayne A
    MAbs; 2014; 6(2):422-36. PubMed ID: 24492301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission.
    Chang XL; Webb GM; Wu HL; Greene JM; Abdulhaqq S; Bateman KB; Reed JS; Pessoa C; Weber WC; Maier N; Chew GM; Gilbride RM; Gao L; Agnor R; Giobbi T; Torgerson J; Siess D; Burnett N; Fischer M; Shiel O; Moats C; Patterson B; Dhody K; Kelly S; Pourhassan N; Magnani DM; Smedley J; Bimber BN; Haigwood NL; Hansen SG; Brown TR; Ndhlovu LC; Sacha JB
    Nat Commun; 2021 Jun; 12(1):3343. PubMed ID: 34099693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy.
    Jiao X; Wang M; Zhang Z; Li Z; Ni D; Ashton AW; Tang HY; Speicher DW; Pestell RG
    Breast Cancer Res; 2021 Jan; 23(1):11. PubMed ID: 33485378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking Placental Class G Immunoglobulin Transfer Prevents NMDA Receptor Antibody Effects in Newborn Mice.
    García-Serra A; Radosevic M; Ríos J; Aguilar E; Maudes E; Landa J; Sabater L; Martinez-Hernandez E; Planagumà J; Dalmau J
    Neurol Neuroimmunol Neuroinflamm; 2021 Nov; 8(6):. PubMed ID: 34580181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal Fc receptor (FcRn): a novel target for therapeutic antibodies and antibody engineering.
    Wang Y; Tian Z; Thirumalai D; Zhang X
    J Drug Target; 2014 May; 22(4):269-78. PubMed ID: 24404896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model.
    Roy S; Nanovskaya T; Patrikeeva S; Cochran E; Parge V; Guess J; Schaeck J; Choudhury A; Ahmed M; Ling LE
    Am J Obstet Gynecol; 2019 May; 220(5):498.e1-498.e9. PubMed ID: 30849355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neonatal Fc receptor : role and implications in maternal fetal medicine].
    Maisonneuve É; Panchaud A; Baud D; Gavillet M
    Rev Med Suisse; 2024 Oct; 20(891):1869-1873. PubMed ID: 39429174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.